NVS
$164.98+3.59%
as of close, Nov 4, 2026
☾ AH $164.98 +3.59%
Novartis AGStock · HealthcareMSCI EAFE · 1.3% of EFAMSCI World · 0.3% of URTHMSCI ACWI · 0.3% of ACWI
Head-to-head:Compare with AMGN or any ticker →
Novartis AG total returns by year (including dividends)
As of market close, Nov 4, 2026
Novartis AG total returns by year (1997–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $137.87 | $164.98 | 3.6% | +23.3% | |
| 2025 | $97.31 | $137.87 | 5.1% | +46.8% | |
| 2024 | $100.97 | $97.31 | 3.7% | +0.1% | |
| 2023 | $90.72 | $100.97 | 4.8% | +16.1% | |
| 2022 | $87.47 | $90.72 | 4.3% | +8.0% | |
| 2021 | $94.43 | $87.47 | 3.5% | -3.9% | |
| 2020 | $94.69 | $94.43 | 3.7% | +3.4% | |
| 2019 | $76.89 | $94.69 | 3.9% | +27.1% | |
| 2018 | $75.23 | $76.89 | 3.7% | +5.9% | |
| 2017 | $65.27 | $75.23 | 4.2% | +19.4% | |
| 2016 | $77.10 | $65.27 | 3.2% | -12.1% | |
| 2015 | $83.03 | $77.10 | 2.5% | -4.7% | |
| 2014 | $72.03 | $83.03 | 3.9% | +19.2% | |
| 2013 | $56.72 | $72.03 | 4.6% | +31.6% | |
| 2012 | $51.23 | $56.72 | 5.0% | +15.7% | |
| 2011 | $52.82 | $51.23 | 4.2% | +1.2% | |
| 2010 | $48.77 | $52.82 | 3.9% | +12.2% | |
| 2009 | $44.59 | $48.77 | 4.9% | +14.2% | |
| 2008 | $48.66 | $44.59 | 2.9% | -5.5% | |
| 2007 | $51.47 | $48.66 | 1.9% | -3.5% | |
| 2006 | $47.03 | $51.47 | 1.8% | +11.2% | |
| 2005 | $45.29 | $47.03 | 1.9% | +5.7% | |
| 2004 | $41.12 | $45.29 | 1.9% | +12.1% | |
| 2003 | $32.91 | $41.12 | 2.4% | +27.4% | |
| 2002 | $32.71 | $32.91 | 1.2% | +1.8% | |
| 2001 | $40.10 | $32.71 | 0.9% | -17.5% | |
| 2000 | $32.82 | $40.10 | 1.4% | +23.6% | |
| 1999 | $43.91 | $32.82 | 0.8% | -24.5% | |
| 1998 | $36.46 | $43.91 | 1.0% | +21.4% | |
| 1997 | $25.76 | $36.46 | 9.3% | +50.9% |
- Annualized
- +9.6%
- 1997–2026
- Average year
- +10.5%
- 29 full years
- Best year
- +50.9%
- 1997
- Worst year
- -24.5%
- 1999
- Positive years
- 22/29
- 76% up
Annualized (CAGR)
+9.6%
1997–2026
Average year
+10.5%
29 full years
Best year
+50.9%
1997
Worst year
-24.5%
1999
Positive years
22/29
76% up
Total return by period#
Annual
-40%-20%0%20%40%
1997+51%'97
1998+21%
1999-24%
2000+24%'00
2001-18%
2002+1.8%
2003+27%'03
2004+12%
2005+5.7%
2006+11%'06
2007-3.5%
2008-5.5%
2009+14%'09
2010+12%
2011+1.2%
2012+16%'12
2013+32%
2014+19%
2015-4.7%'15
2016-12%
2017+19%
2018+5.9%'18
2019+27%
2020+3.4%
2021-3.9%'21
2022+8.0%
2023+16%
2024+0.06%'24
2025+47%
2026+23%
Methodology#
Total returns, dividends reinvested, measured on NVS. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Novartis AG's average annual return?
- Since 1997, Novartis AG (NVS) has returned about 9.6% a year (the compound annual growth rate) and an average calendar-year return of 10.5%.
- What were Novartis AG's best and worst years?
- Over 1997–2026, the best year was 1997 (+50.9%) and the worst was 1999 (-24.5%).
- How often is Novartis AG up in a year?
- 22 of the 29 full years since 1997 were positive — about 76% of the time.
More on Novartis AG
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with AMGN or any ticker →